Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Christina Davies, Hongchao Pan, Jon Godwin et al. · The Lancet · 2012 · 2K citations · Full text

Medicine, Endocrinology, Oncology +14

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Chad J. Creighton, Xiaoxian Li, Melissa D. Landis et al. · Proceedings of the National Academy of Sciences · 2009 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +16

Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland

Katherine E Sleeman, Howard Kendrick, David Robertson et al. · The Journal of Cell Biology · 2006 · 318 citations · Full text

Life Sciences, Cell Biology, Endocrinology +16

Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation

Lesley‐Ann Martin, Ian Farmer, Stephen Johnston et al. · Journal of Biological Chemistry · 2003 · 295 citations · Full text

Life Sciences, Cell Biology, Endocrinology +17

Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

Christine M. Fillmore, Piyush B. Gupta, Jenny A. Rudnick et al. · Proceedings of the National Academy of Sciences · 2010 · 282 citations · Full text

Life Sciences, Cell Biology, Oncology +17